|
| COMPLAINT for ANDA/PATENT INFRINGEMENT against All Defendants (Filing fee $ 402, receipt number ADEDC-4000296.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Civil Cover Sheet) (vfm) (Entered: 11/07/2022) |
| ANSWER to 1 Complaint, , COUNTERCLAIM against Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc. by Teva Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) (Entered: 01/06/2023) |
| ANSWER to 12 Answer to Complaint, Counterclaim by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc..(Stover, Chad) (Entered: 02/17/2023) |
| AMENDED COMPLAINT against Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc.- filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Stover, Chad) (Entered: 06/08/2023) |
| AMENDED COMPLAINT against Lupin Ltd., Lupin Pharmaceuticals, Inc.- filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Stover, Chad) (Entered: 06/08/2023) |
| ANSWER to Amended Complaint, re: 37 Amended Complaint, Affirmative Defenses , COUNTERCLAIM against Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc. by Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) (Entered: 06/22/2023) |
| ANSWER to Amended Complaint, re: 38 Amended Complaint, Affirmative Defenses , COUNTERCLAIM against All Plaintiffs by Lupin Pharmaceuticals, Inc., Lupin Ltd..(Phillips, John) (Entered: 06/22/2023) |
| Second AMENDED COMPLAINT for Patent Infringement against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.- filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A-N, # 2 Exhibit O-W, # 3 Exhibit X-CC, # 4 Patent/Trademark Report)(Stover, Chad) (Entered: 07/12/2023) |
| ANSWER to 50 Answer to Amended Complaint, Counterclaim by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc..(Stover, Chad) (Entered: 07/13/2023) |
| ANSWER to 48 Answer to Amended Complaint,, Counterclaim, by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc..(Stover, Chad) (Entered: 07/13/2023) |
| ANSWER to Amended Complaint, re: 56 Amended Complaint, by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Myer, R.) (Entered: 07/26/2023) |